DVA:NYSE
Davita Inc
179,25 USD
arrow_upward
+1,26%(+2,23) 1D
179,25 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 9. lis, 16:00:03 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za DVA...
Otvori
177,00 USD
Najviša
180,11 USD
Najniža
177,00 USD
Trž. kap.
11,44 mlr.
Prosj. kol.
659,00 tis.
Količina
369,64 tis.
P/E omjer
14,68
52-tjed. najviša
247,49 USD
52-tjed. najniža
101,00 USD
EPS
12,21 USD
Beta
0,80
Dionice u optjecaju
63,80 mil.
Broj djelatnika
78 tis.
Otvori
177,00 USD
Najviša
180,11 USD
Najniža
177,00 USD
Trž. kap.
11,44 mlr.
Prosj. kol.
659,00 tis.
Količina
369,64 tis.
P/E omjer
14,68
52-tjed. najviša
247,49 USD
52-tjed. najniža
101,00 USD
EPS
12,21 USD
Beta
0,80
Dionice u optjecaju
63,80 mil.
Broj djelatnika
78 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Zacks
·
prije 1 dan
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
News Corp
·
prije 1 dan
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains
MarketWatch
·
prije 1 dan
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains
Seeking Alpha
·
prije 1 dan
DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again (NYSE:DVA)
Profil
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
Davita Inc – informacije
Glavni izvršni direktorJavier J. Rodriguez
Zaposlenici78 tis.
Osnovano1992
SjedišteDenver, Colorado, Sjedinjene Američke Države
SektorHealth care provider
Web-lokacijadavita.com